MRK

$

(%)

Exchange:
Market Cap:
Shares Outstanding:

About The Company

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

It’s free

EPS

🔒 You are currently logged out

It’s free

View full analyst estimates

Earnings Call

🔒 You are currently logged out

It’s free

Income Statement

Balance Sheet

Cash Flow Statement

Analyst Estimates

Income Statement

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Balance Sheet

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Cash Flow Statement

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Analyst Estimates

(* All numbers are in thousands)

🔒 You are currently logged out

It’s free

Current Key Metrics

🔒 You are currently logged out

It’s free

Forward P/E Ratios

🔒 You are currently logged out

It’s free

SWOT Analysis

🔒 You are currently logged out

It’s free

At what price to buy it? –
Intrinsic Value Calculator

Calculate MRK Intrinsic Value

🔒 You are currently logged out

It’s free

Relevant news

FDA Approves MRK’s Keytruda & Keytruda SC Combo in Bladder Cancer

21-11-2025 19:30

Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer

21-11-2025 16:12

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cispl

20-11-2025 12:13

Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference 2025 Transcript

19-11-2025 13:23

Merck’s Investigational Two-Drug Regime Matches Gilead’s Three-Drug Tablet For HIV Treatment